ArticlePloS one2017

Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.

Yuping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.